| RS121434342 |
CHD7
|
Health Risk |
Pathogenic |
CHARGE syndrome, CHARGE syndrome |
| RS121434343 |
CHD7
|
Health Risk |
Pathogenic/Likely pathogenic |
CHARGE syndrome, CHARGE syndrome |
| RS121434344 |
CHD7
|
Health Risk |
Pathogenic |
CHARGE syndrome, HYPOGONADOTROPIC HYPOGONADISM 5 WITHOUT ANOSMIA |
| RS121434346 |
SLC6A19
|
Health Risk |
Pathogenic/Likely pathogenic |
Neutral 1 amino acid transport defect, Iminoglycinuria |
| RS121434347 |
SLC6A19
|
Health Risk |
Pathogenic |
Neutral 1 amino acid transport defect, Iminoglycinuria |
| RS121434348 |
AHI1
|
Health Risk |
Pathogenic |
Joubert syndrome 3, Joubert syndrome |
| RS121434349 |
AHI1
|
Health Risk |
Pathogenic |
Joubert syndrome 3, Joubert syndrome |
| RS121434350 |
AHI1
|
Health Risk |
Pathogenic/Likely pathogenic |
Joubert syndrome 3, Typical Joubert syndrome MRI findings |
| RS121434351 |
AHI1
|
Health Risk |
Conflicting classifications of pathogenicity |
Joubert syndrome 3, Joubert syndrome |
| RS121434352 |
UNC13D
|
Health Risk |
Pathogenic/Likely pathogenic |
Familial hemophagocytic lymphohistiocytosis 3, Autoinflammatory syndrome |
| RS121434353 |
UNC13D
|
Health Risk |
Pathogenic |
Familial hemophagocytic lymphohistiocytosis 3, Familial hemophagocytic lymphohistiocytosis |
| RS121434354 |
UNC13D
|
Health Risk |
Pathogenic |
Familial hemophagocytic lymphohistiocytosis 3, Familial hemophagocytic lymphohistiocytosis 3 |
| RS121434356 |
FREM2
|
Health Risk |
Conflicting classifications of pathogenicity |
Fraser syndrome 2, Isolated cryptophthalmia |
| RS121434357 |
ADAMTS10
|
Health Risk |
Pathogenic |
Weill-Marchesani syndrome 1, Weill-Marchesani syndrome 1 |
| RS121434359 |
ADAMTS10
|
Health Risk |
Pathogenic |
Weill-Marchesani syndrome 1, Weill-Marchesani syndrome 1 |
| RS121434360 |
D2HGDH
|
Health Risk |
Pathogenic |
D-2-hydroxyglutaric aciduria 1, D-2-hydroxyglutaric aciduria 1 |
| RS121434361 |
D2HGDH
|
Health Risk |
Pathogenic |
D-2-hydroxyglutaric aciduria 1, D-2-hydroxyglutaric aciduria 1 |
| RS121434362 |
D2HGDH
|
Health Risk |
Pathogenic |
D-2-hydroxyglutaric aciduria 1, D-2-hydroxyglutaric aciduria 1 |
| RS121434363 |
SLC39A13
|
Health Risk |
Conflicting classifications of pathogenicity |
Ehlers-Danlos syndrome, spondylocheirodysplastic type |
| RS121434364 |
GTF2H5
|
Health Risk |
Pathogenic/Likely pathogenic |
Trichothiodystrophy 3, photosensitive |
| RS121434365 |
GTF2H5
|
Health Risk |
Pathogenic |
Trichothiodystrophy 3, photosensitive |
| RS121434366 |
GCDH
|
Health Risk |
Pathogenic/Likely pathogenic |
Glutaric aciduria, type 1 |
| RS121434367 |
GCDH
|
Health Risk |
Pathogenic |
Glutaric aciduria, type 1 |
| RS121434368 |
GCDH
|
Health Risk |
Likely pathogenic |
Glutaric aciduria, type 1 |
| RS121434369 |
GCDH
|
Health Risk |
Pathogenic |
Glutaric aciduria, type 1 |
| RS121434370 |
GCDH
|
Health Risk |
Likely pathogenic |
Glutaric aciduria, type 1 |
| RS121434371 |
GCDH
|
Health Risk |
Pathogenic |
Glutaric aciduria, type 1 |
| RS121434372 |
GCDH
|
Health Risk |
Pathogenic |
Glutaric aciduria, type 1 |
| RS121434373 |
GCDH
|
Health Risk |
Conflicting classifications of pathogenicity |
Glutaric aciduria, type 1 |
| RS121434374 |
HJV
|
Health Risk |
Pathogenic |
Hemochromatosis type 2A, Hemochromatosis type 1 |
| RS121434375 |
HJV
|
Health Risk |
Pathogenic |
Hemochromatosis type 2A, Hemochromatosis type 2A |
| RS121434376 |
SETX
|
Health Risk |
Pathogenic |
Spinocerebellar ataxia, autosomal recessive |
| RS121434377 |
SETX
|
Health Risk |
Pathogenic |
Spinocerebellar ataxia, autosomal recessive |
| RS121434378 |
SETX
|
Health Risk |
Likely pathogenic |
Amyotrophic lateral sclerosis type 4, Distal spinal muscular atrophy |
| RS121434379 |
SETX
|
Health Risk |
Pathogenic |
Spinocerebellar ataxia, autosomal recessive |
| RS121434380 |
SETX
|
Health Risk |
Conflicting classifications of pathogenicity |
Spinocerebellar ataxia, autosomal recessive |
| RS121434381 |
SETX
|
Health Risk |
Pathogenic |
Spinocerebellar ataxia, autosomal recessive |
| RS121434382 |
HMCN1
|
Health Risk |
Conflicting classifications of pathogenicity |
MACULAR DEGENERATION, AGE-RELATED |
| RS121434383 |
VPS33B
|
Health Risk |
Pathogenic |
Arthrogryposis, renal dysfunction |
| RS121434384 |
VPS33B
|
Health Risk |
Pathogenic |
Arthrogryposis, renal dysfunction |
| RS121434385 |
VPS33B
|
Health Risk |
Pathogenic |
Arthrogryposis, renal dysfunction |
| RS121434387 |
COG8
|
Health Risk |
Pathogenic |
COG8-congenital disorder of glycosylation, COG8-congenital disorder of glycosylation |
| RS121434389 |
RPL11
|
Health Risk |
Pathogenic |
Diamond-Blackfan anemia 7, Diamond-Blackfan anemia |
| RS121434390 |
TRPC6
|
Health Risk |
Pathogenic |
Focal segmental glomerulosclerosis 2, Focal segmental glomerulosclerosis 2 |
| RS121434392 |
TRPC6
|
Health Risk |
Pathogenic |
Focal segmental glomerulosclerosis 2, Focal segmental glomerulosclerosis 2 |
| RS121434393 |
TRPC6
|
Health Risk |
Conflicting classifications of pathogenicity |
Focal segmental glomerulosclerosis 2, Focal segmental glomerulosclerosis 2 |
| RS121434394 |
TRPC6
|
Health Risk |
Pathogenic |
Focal segmental glomerulosclerosis 2, Nephrotic syndrome |
| RS121434395 |
TRPC6
|
Health Risk |
Pathogenic/Likely pathogenic |
Focal segmental glomerulosclerosis 2, Inborn genetic diseases |
| RS121434396 |
SLC25A12
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 39 |
| RS121434402 |
MTMR2
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease type 4B1, Charcot-Marie-Tooth disease type 4 |
| RS121434403 |
MTMR2
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease type 4B1, Charcot-Marie-Tooth disease type 4B1 |
| RS121434404 |
MTMR2
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease type 4B1, Charcot-Marie-Tooth disease type 4B1 |
| RS121434405 |
RPL5
|
Health Risk |
Pathogenic |
Diamond-Blackfan anemia 6, Diamond-Blackfan anemia |
| RS121434406 |
DIPK1A;RPL5
|
Health Risk |
Conflicting classifications of pathogenicity |
Diamond-Blackfan anemia 6, Diamond-Blackfan anemia |
| RS121434407 |
GLE1
|
Health Risk |
Pathogenic/Likely pathogenic |
Lethal congenital contracture syndrome 1, Inborn genetic diseases |
| RS121434408 |
GLE1
|
Health Risk |
Pathogenic |
Lethal arthrogryposis-anterior horn cell disease syndrome, Lethal arthrogryposis-anterior horn cell disease syndrome |
| RS121434409 |
GLE1
|
Health Risk |
Pathogenic |
Lethal arthrogryposis-anterior horn cell disease syndrome, Lethal arthrogryposis-anterior horn cell disease syndrome |
| RS121434410 |
PRKRA
|
Health Risk |
Pathogenic/Likely pathogenic |
Dystonia 16, PRKRA-related disorder |
| RS121434411 |
AGPS
|
Health Risk |
Likely pathogenic |
Rhizomelic chondrodysplasia punctata type 3, Rhizomelic chondrodysplasia punctata type 3 |
| RS121434412 |
AGPS
|
Health Risk |
Likely pathogenic |
Rhizomelic chondrodysplasia punctata type 3, Rhizomelic chondrodysplasia punctata |
| RS121434413 |
AGPS
|
Health Risk |
Pathogenic |
Rhizomelic chondrodysplasia punctata type 3, Rhizomelic chondrodysplasia punctata type 3 |
| RS121434415 |
PNPLA6
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 39, Ataxia-hypogonadism-choroidal dystrophy syndrome |
| RS121434416 |
PNPLA6
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 39, Hereditary spastic paraplegia 39 |
| RS121434417 |
BMPR1B
|
Health Risk |
Likely pathogenic |
Type A2 brachydactyly, Type A2 brachydactyly |
| RS121434418 |
BMPR1B
|
Health Risk |
Pathogenic |
Type A2 brachydactyly, Acromesomelic dysplasia 3 |
| RS121434419 |
BMPR1B
|
Health Risk |
Likely pathogenic |
Type A2 brachydactyly, BMPR1B-related disorder |
| RS121434420 |
PKP2
|
Health Risk |
Pathogenic |
Arrhythmogenic right ventricular dysplasia 9, Cardiovascular phenotype |
| RS121434421 |
PKP2
|
Health Risk |
Pathogenic |
Arrhythmogenic right ventricular dysplasia 9, Arrhythmogenic right ventricular cardiomyopathy |
| RS121434422 |
CERS1;GDF1;UPF1
|
Health Risk |
Pathogenic/Likely pathogenic |
Congenital heart defects, multiple types |
| RS121434424 |
GDF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Tetralogy of Fallot, GDF1-related disorder |
| RS121434425 |
FANCG
|
Health Risk |
Pathogenic |
Fanconi anemia complementation group G, Fanconi anemia |
| RS121434426 |
FANCG
|
Health Risk |
Pathogenic |
Fanconi anemia complementation group G, Fanconi anemia |
| RS121434427 |
NDUFS2
|
Health Risk |
Conflicting classifications of pathogenicity |
Mitochondrial complex I deficiency, nuclear type 6 |
| RS121434428 |
NDUFS2
|
Health Risk |
Pathogenic |
Mitochondrial complex I deficiency, nuclear type 6 |
| RS121434429 |
NDUFS2
|
Health Risk |
Likely pathogenic |
Mitochondrial complex I deficiency, nuclear type 6 |
| RS121434430 |
CUBN
|
Health Risk |
Pathogenic/Likely pathogenic |
Imerslund-Grasbeck syndrome, Imerslund-Grasbeck syndrome type 1 |
| RS121434432 |
CLCN7
|
Health Risk |
Pathogenic |
Autosomal recessive osteopetrosis 4, Autosomal recessive osteopetrosis 4 |
| RS121434433 |
CLCN7
|
Health Risk |
Pathogenic |
Autosomal recessive osteopetrosis 4, Autosomal recessive osteopetrosis 4 |
| RS121434434 |
CLCN7
|
Health Risk |
Pathogenic |
Autosomal recessive osteopetrosis 4, Autosomal recessive osteopetrosis 4 |
| RS121434435 |
CLCN7
|
Health Risk |
Pathogenic |
Autosomal dominant osteopetrosis 2, Autosomal recessive osteopetrosis 4 |
| RS121434436 |
CLCN7
|
Health Risk |
Pathogenic |
Autosomal recessive osteopetrosis 4, Autosomal recessive osteopetrosis 4 |
| RS121434439 |
GNPAT
|
Health Risk |
Pathogenic |
Rhizomelic chondrodysplasia punctata type 2, Rhizomelic chondrodysplasia punctata type 2 |
| RS121434440 |
GNPAT
|
Health Risk |
Likely pathogenic |
Rhizomelic chondrodysplasia punctata type 2, Rhizomelic chondrodysplasia punctata |
| RS121434441 |
KIF5A
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 10, Hereditary spastic paraplegia 10 |
| RS121434442 |
KIF5A
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary spastic paraplegia 10, Spastic paraplegia |
| RS121434443 |
KIF5A
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary spastic paraplegia 10, Spastic paraplegia |
| RS121434444 |
KIF5A
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary spastic paraplegia 10, Spastic paraplegia |
| RS121434447 |
TRIM32
|
Health Risk |
Conflicting classifications of pathogenicity |
Sarcotubular myopathy, Bardet-Biedl syndrome |
| RS121434448 |
HR
|
Health Risk |
Pathogenic |
Alopecia universalis congenita, Alopecia universalis congenita |
| RS121434449 |
HR
|
Health Risk |
Pathogenic |
Atrichia with papular lesions, Atrichia with papular lesions |
| RS121434450 |
HR
|
Health Risk |
Pathogenic |
Atrichia with papular lesions, Atrichia with papular lesions |
| RS121434451 |
HR
|
Health Risk |
Pathogenic |
Alopecia universalis congenita, Alopecia universalis congenita |
| RS121434453 |
MT-TE
|
Health Risk |
Likely pathogenic |
Myopathy, mitochondrial |
| RS121434455 |
PEX1
|
Health Risk |
Likely pathogenic |
Peroxisome biogenesis disorder 1A (Zellweger), Heimler syndrome 1 |
| RS121434457 |
MT-TA
|
Health Risk |
Likely pathogenic |
Myotonic dystrophy-like myopathy, Mitochondrial disease |
| RS121434459 |
PLOD2
|
Health Risk |
Pathogenic |
Bruck syndrome 2, Bruck syndrome 2 |
| RS121434460 |
PLOD2
|
Health Risk |
Pathogenic |
Bruck syndrome 2, Bruck syndrome 2 |
| RS121434461 |
PLOD2
|
Health Risk |
Likely pathogenic |
Bruck syndrome 2, Bruck syndrome 2 |
| RS121434462 |
MT-TL2
|
Health Risk |
Likely pathogenic |
Mitochondrial encephalomyopathy, MELAS syndrome |
| RS121434470 |
MT-TI
|
Health Risk |
Likely pathogenic |
Primary familial hypertrophic cardiomyopathy, Asymmetric septal hypertrophy |